Expertise in
39
conditions

Dr. Keith M. Rich

Neurosurgery
Office
660 S Euclid Ave Ste 8057, 
Saint Louis, MO 
Accepting New Patients
Expertise in
39
conditions
Office
660 S Euclid Ave Ste 8057, 
Saint Louis, MO 

Overview

Keith Rich is a Neurosurgery provider practicing medicine in Saint Louis, Missouri.

Dr. Rich is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Meningioma, Glioma, Endovascular Embolization, and Gamma Knife Radiosurgery.

He is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 5 clinical trials. Dr. Rich is currently accepting new patients.

Specialties

Neurosurgery

Licenses

Neurological Surgery in MO

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cox Health
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO

Locations

Office
660 S Euclid Ave Ste 8057, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized in Patients With Newly Diagnosed, Unmethylated Glioblastoma
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2026
Intervention Type: Device, Biological, Drug
Study Drugs: Personalized neoantigen DNA vaccine, Plasmid encoded IL-12
Study Phase: Phase 1
A Phase I/II Dose-escalation and Dose-expansion Study of Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
A Phase I/II Dose-escalation and Dose-expansion Study of Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: April 10, 2025
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Disulfiram, Copper Gluconate, Temozolomide
Study Phase: Phase 1/Phase 2
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Enrollment Status: Terminated
Publish Date: October 27, 2021
Intervention Type: Procedure, Biological
Study Phase: Phase 1
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Doxorubicin in the Treatment of Recurrent Glioblastoma Multiforme
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Doxorubicin in the Treatment of Recurrent Glioblastoma Multiforme
Enrollment Status: Completed
Publish Date: August 27, 2021
Intervention Type: Device, Drug, Other
Study Phase: Phase 1
A Pilot Study to Assess the Safety, Feasibility, and Preliminary Efficacy of a Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
A Pilot Study to Assess the Safety, Feasibility, and Preliminary Efficacy of a Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Terminated
Publish Date: November 17, 2017
Intervention Type: Drug, Biological
Study Phase: Phase 1
View 4 Less Clinical Trials

84 Total Publications

Postoperative fluid restriction to prevent delayed hyponatremia after endoscopic transsphenoidal surgery.
Postoperative fluid restriction to prevent delayed hyponatremia after endoscopic transsphenoidal surgery.
Journal: Neuro-oncology
Published: March 14, 2025
Similar Doctors
Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

St. Louis Children's Hospital

1 Childrens Pl, 
Saint Louis, MO 
 (0.8 miles away)
314-454-2810
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Limbrick is a Neurosurgery provider practicing medicine in Saint Louis, Missouri. Dr. Limbrick is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Chiari Malformation Type 2, Syringomyelia, Hydrocephalus, Posterior Fossa Decompression, and Nerve Decompression. Dr. Limbrick is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

Office

1 Childrens Pl Ste 4S20, 
Saint Louis, MO 
 (0.1 miles away)
314-454-2810
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jennifer Strahle is a Neurosurgery provider practicing medicine in Saint Louis, Missouri. Dr. Strahle is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Chiari Malformation Type 2, Syringomyelia, Chiari Malformation, Posterior Fossa Decompression, and Endoscopy. Dr. Strahle is currently accepting new patients.

Expertise in
72
conditions
Expertise in
72
conditions
Referral may be required

Office

4921 Parkview Pl Ste 6C, 
Saint Louis, MO 
 (0.7 miles away)
314-362-3577
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Chicoine is a Neurosurgery provider practicing medicine in Saint Louis, Missouri. Dr. Chicoine is highly rated in 72 conditions, according to our data. His clinical expertise encompasses Meningioma, Pituitary Tumor, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Nerve Decompression. Dr. Chicoine is currently accepting new patients.

Frequently Asked Questions about Dr. Keith M. Rich

How do I make an appointment with Dr. Keith M. Rich?

You can book an appointment with Dr. Keith M. Rich by calling their office at 314-362-3566. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Keith M. Rich a top-rated expert for Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Keith M. Rich is classified as an Elite expert for Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Keith M. Rich specialize in?

While Dr. Keith M. Rich is a Neurosurgery, they have specific expertise in Brain Tumor, Meningioma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Keith M. Rich participate in research or clinical trials?

Yes. Dr. Keith M. Rich has published 84 articles and abstracts on conditions like Brain Tumor. You can view a list of Dr. Keith M. Rich's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Keith M. Rich accept my insurance?

Dr. Keith M. Rich accepts most major insurance plans, including Aetna and Cox Health. We recommend calling the office directly at 314-362-3566 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rich's expertise for a condition
ConditionClose
View All 12 Distinguished Conditions
View All 26 Advanced Conditions
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile